HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

O Ghirardi Selected Research

Obesity

7/2006Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


O Ghirardi Research Topics

Disease

1Body Weight (Weight, Body)
07/2006
1Hyperinsulinism (Hyperinsulinemia)
07/2006
1Obesity
07/2006
1Weight Gain
07/2006
1Dyslipidemias (Dyslipidemia)
07/2006

Drug/Important Bio-Agent (IBA)

1antiarrhythmic peptide (AAP)IBA
07/2006
1Olanzapine (Zyprexa)FDA Link
07/2006
1Fatty Acids (Saturated Fatty Acids)IBA
07/2006
1Glucose (Dextrose)FDA LinkGeneric
07/2006
1Insulin (Novolin)FDA Link
07/2006
1Antipsychotic Agents (Antipsychotics)IBA
07/2006
1Triglycerides (Triacylglycerol)IBA
07/2006